Drugs / SPARC1507
last change Dec 2019 re-read 3 minutes ago

SPARC1507

Developed for
biliary tract cancer
Investigated by
Sun Pharma Advanced Research Company Limited

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02597465 Dec 2018 → Mar 2019 biliary tract cancer Sun Pharma Advanced Research Company Limited Withdrawn No outcome recorded Stop: Business

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SPARC1507 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02597465 ↗